NEW YORK (GenomeWeb) – OpGen announced today that it has signed a supply agreement with Thermo Fisher Scientific to combine its Acuitas Rapid Test for Pathogen ID with Thermo Fisher's real-time PCR solutions.

The deal is intended to help support the commercialization of OpGen's rapid molecular products and informatics system to help combat multidrug-resistant infections, the company said. Combining genomic analysis with bioinformatics can help healthcare providers efficiently and accurately identify bacterial antibiotic susceptibility, it added.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.